Researchers at the pharmaceutical company plan to administer two doses of the mRNA gene therapy to some 4,464 children from Europe and the U.S. as part of a 3-phase trial process.
The source article by LifeSite was taken down for reasons unknown. However, hyperlinks to source material used by LifeSite are included in the body of this re-post.
The baby girl, whose name was not publicized received her second and final dose of the serum on February 25. According to the record in the Vaccine Adverse Event Reporting System (VAERS) — a vaccine injury recording system run jointly by the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) — the infant was admitted to the hospital on February 14, meaning that she had already received her first dose before being hospitalized for 17 days.
The VAERS record indicates that the baby did not have any pre-existing conditions, birth defects, or permanent disabilities, but that she developed a serious side-effect on March 1, four days after receiving her second dose, while she was still in hospital following the first shot. Two days later, on March 3, she was dead.
As things stand, no person under the age of 16 is legally eligible to receive the Pfizer-developed COVID jab. The drug giant has, however, begun conducting experiments on healthy children between six months and eleven years of age, beginning last month. The drug maker wants to “evaluate the safety, tolerability, and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine.”
Researchers at the pharmaceutical company plan to administer two doses of the mRNA gene therapy to some 4,464 children from Europe and the U.S. as part of a 3-phase trial process. Results are expected “in the second half of 2021,” and, “pending agreement with and endorsement from regulators,” the company hopes “to receive authorization for vaccination of these younger kids by early 2022,” Pfizer’s website details.
Moderna also started trials of their mRNA vaccine on children younger than 12 years in March, enrolling 6,750 children throughout the U.S. and Canada into the program, though persons under 18 years are normally prohibited from receiving the jab.
Moderna stated that its own study “is being conducted in collaboration with the National Institute of Allergy and Infectious Diseases (NIAID),” the agency within the National Institutes of Health under the direction of Dr. Anthony Fauci, who also serves as the chief medical advisor to President Joe Biden and is the world’s foremost COVID “vaccine” apologist.
As parents enter their children into experimental COVID vaccine trials — over 11,000 children being enrolled in such programs combined — the evidence of injury from mRNA “vaccines” mounts daily. VAERS data, collected from December 14 until April 8, revealed a total of 68,347 adverse event reports. Of that total, 8,285 were considered “serious injuries,” and 2,602 were deaths.
795 cases of blood clotting disorders were reported during that time period, over fifty percent of which are at least temporally connected to the Pfizer vaccine, and a total of 114 miscarriages. In spite of the deaths of those children in the womb, a recent CDC study, published Wednesday in the New England Journal of Medicine, concluded that there are no “obvious safety signals among pregnant persons who received mRNA COVID-19 vaccines.”
The study considered a pool of 35,691 “participants … identified as pregnant,” drawn from the CDC’s “V-safe COVID-19 Vaccine Pregnancy Registry” and related “V-safe After Vaccine Health Checker.” The study also included information available on VAERS. Within the V-safe pregnancy registry, 3,958 pregnant women, fully vaccinated with an mRNA-derived product, were enrolled. 827 women completed their pregnancy before the end of the study period on February 28, 2021. Of that number, 115 miscarried (13.9%). The results also documented 60 premature births and 23 babies born abnormally small.
While no neonatal deaths were recorded, 16 cases of “major congenital anomalies” were reported in the V-safe database. VAERS reports, according to the study, showed that “the most frequently reported pregnancy-related adverse event” was “spontaneous abortion,” accounting for 46 deaths. This was followed by “stillbirth, premature rupture of membranes, and vaginal bleeding, with 3 reports for each.”
The authors of the study, though concluding that the above data “did not show obvious safety signals,” admitted that its findings were “preliminary,” requiring “more longitudinal follow-up.”